GMED
Globus Medical·NYSE
--
--(--)
--
--(--)
4.73 / 10
Netural
Analyst consensus is overwhelmingly bullish (100% Strong Buy from David Saxon, Needham), yet historical win rate is low (20%). Fund flow is robust (7.68/10) with positive small-cap inflows but negative overall trends, hinting at short-term pressure. Together, sentiment and flow provide cautious optimism amid neutral fundamentals and technicals.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-30
InstitutionNeedham
Times predicted5
Historical Win Rate20.0%
Is money flowing into or out of GMED?
- GMED holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 4.73/10 (Netural).
